Physician profile
Moqueet Qureshi
NPI 1851573281
$23,067.81
in general payments reported to CMS, 2019-2025
21 companies · $6,098 in 2025
The $6,098 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $111 · 2021: $317 · 2022: $2,253 · 2023: $7,121 · 2024: $6,942 · 2025: $6,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $17K · Food and Beverage: $2,828 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $16,833.33 |
| Food and Beverage | $2,827.52 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18,273.98 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $1,327.45 | 2021-2025 | Endurant Iis, Abre, Ellipsys Vascular Access System |
| Inari Medical, INC. | $1,126.26 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $645.61 | 2019-2025 | Eluvia, Seismiq Lithotrip_pi, Embold Fibered |
| Endologix LLC | $332.80 | 2022-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Cook Medical LLC | $298.09 | 2019-2025 | Zenith Spiral-Z, Zenith Alpha, Advance |
| Stryker Corporation | $253.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Lemaitre Vascular, INC. | $206.22 | 2021-2024 | Artegraft Vascular Graft, Trivex System |
| W. L. Gore & Associates, INC. | $152.81 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| E.R. Squibb & Sons, L.L.C. | $139.56 | 2022-2024 | Eliquis |
| Pfizer INC. | $56.51 | 2023-2024 | |
| Abbott Laboratories | $42.83 | 2023-2025 | Jeti Peripheral Catheter, Esprit |
| Tactile Systems Technology INC | $40.92 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Solventum Corporation | $34.77 | 2025 | Activ.A.C., Prevena, Promogran Prisma |
| Janssen Pharmaceuticals, INC | $31.73 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $24.44 | 2023 | Cardiva Vascade 6/7f Vcs |
| Convatec INC. | $18.51 | 2023 | |
| Reprise Biomedical, INC. | $17.58 | 2023 | Miro3d |
| Biotronik INC. | $15.75 | 2022 | |
| Cardiovascular Systems INC. | $14.71 | 2021 | |
| Cordis US Corp. | $14.19 | 2024 | Mynx Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moqueet Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.